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Abstract 
We have used a scallop hybrid myosin test system in an attempt to determine the regulatory properties of an individual myosin II isoform from 
rat brain. The complete coding region of cDNA corresponding to a regulatory light chain isoform previously shown to be expressed in brain [Feinstein, 
Durand and Milner (1991) Mol. Brain Res. 10,97-1051 was ligated within the prokaryotic expression vector,pAED4, overexpressed in bacteria, and 
the purified light chain incorporated within a scallop hybrid myosin. Actin activation was calcium insensitive for all hybrids tested, irrespective of 
whether light chain phosphorylation had taken place before, or subsequent to, hybrid formation. We discuss the implications of these results, including 
the possibility that these results constitute evidence for a myosin II isoform within brain that is regulated at the level of the thin filament. In addition, 
evidence is presented for the presence of an additional, novel isoform of regulatory light chain expressed in rat brain. 
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1. Introduction 
The interaction between myosin II and actin may be 
controlled by actin-linked or myosin-linked mechanisms 
of regulation [l]. In the latter case, light chains present 
within the heads of regulatory myosins are able to con- 
trol the level of interaction between actin and myosin [2]. 
This is in contrast to thin filament linked regulation 
where the major regulatory components are associated 
with the actin containing thin filament [3]. Reversible 
removal of regulatory light chains (RLCs) from scallop 
myosin [4,5] has facilitated the formation of hybrid 
myosins, permitting classification of the regulatory sys- 
tem from which the guest RLC was obtained [6-81 and 
creation of an in vitro test system for mutant light chains 
[9-111. Whereas RLCs from striated muscle myosins 
could not restore calcium sensitivity to desensitized scal- 
lop myosin [6-81, RLCs from myosins controlled by di- 
rect calcium binding or by RLC phosporylation could 
restore regulation [7,8,12]. 
When myosin II is isolated in bulk from brain, the 
preparation is necessarily representative of a mixture of 
isoforms, variously present in neurons, glia and vascular 
smooth muscle cells [13-l 61, thereby making direct func- 
tional assessment of individual myosin isoforms impossi- 
ble. An alternative approach in achieving this goal is 
possible through the construction and testing of hybrid 
*Corresponding author. Fax: (44) (71) 388-2342/1027. 
Abbreviations: EGTA, ethylene glycol bis(aminoethy1 ether)N,N,hr,N’- 
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light chain; MLCK, myosin light chain kinase. 
myosins, using individual RLC isoforms which are pro- 
duced by overexpression in bacteria from single clones. 
To this end we have screened a rat brain cDNA library 
so as to clone and express RLC isoforms previously 
located in brain [17]. The purified RLC was tested for 
regulatory capability as a component of scallop hybrid 
myosin, both as a function of calcium and of RLC phos- 
phorylation. Direct sequencing evidence for the presence 
of at least three RLC isofoims from rat brain was ob- 
tained, including evidence for a novel isoform. A prelim- 
inary account of this work has been presented earlier 
[181. 
2. Materials and methods 
Clones (5 x 10’) from a rat brain cDNA expression library (Strat- 
agene) were screened using two 3’ end-labeled (End-All Labeling Bio- 
systems, IBI) 36-mer probes designed to hybridize to conserved se- 
quences found in both of two RLC isoforms located in brain [17,22]. 
The oligonucleotides were 5’-CAGGAGTTCAAAGAGGCCTICAA- 
CATGATCGACCAG-3’ and S-GAGTTCACGCGCATCCTCAAG- 
CACGGAGCGAAAGAC-3’, corresponding to amino acids 3243 
and 158-169, respectively, in both RLCs. Final washes were performed 
in 0.5 x SSC and 0.2% SDS at 42°C. Inserts inpBluescript (Stratagene) 
were sequenced using Sequenase 2.0 (U.S.B.) and the dideoxy chain 
termination method [19]. 
A RLC expression plasmid was created by cloning full length RLC 
cDNA into the expression plasmid pAED (courtesy of Dr. Don Doer- 
ing, Whitehead Institute, Cambridge, MA). The full-length insert was 
obtained by DNA amplification (10 ng template DNA, 500 ng of each 
primer, 25 cycles of 95°C (1 min), 50°C (2 min) and 72°C (3 min) on 
a thermal cycler using 5’ (S-AACCGCCCATATGTCGAGCAAAA- 
AAGCA-3’) and 3’ (5’-TCAACAGGAATGTCAGCTGCAGCTCT- 
TC-3’) primers. NdeI and PvuII sites (underlined) are incorporated 
within the 5’ and 3’ primers, repectively. Both the amplification product 
and the vector were digested with NdeIlPvuII and products isolated by 
agarose gel electrophoresis, then ligated together with T4-DNA ligase. 
It may be noted that creation of the NdeI site by in vitro mutagenesis 
facilitated ligation of the amplification product immediately in front of 
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the ATG start site and downstream of the T7 promoter. The completed 
expression plasmid was transformed into E. coli BL21 and the RLC 
insert resequenced so as to confirm the absence of any spontaneous 
mutation during amplification. 
Overnight cultures of E. coli BL21 transformed with expression plas- 
mid pAED containing the full length RLC cDNA were diluted_lOO- 
fold, then regrown to an ODW of 0.54.6 before induction with IPTG 
(final concentration 0.4 mM). After 5 h, bacteria were pelleted and 
solubilized overnight in 8 M guanidine hydrochloride prior to ethanol 
ureciuitation and RLC ourification as described nreviouslv 1201. 
Standard procedures-were used to prepare intact and desensitized 
scallop myofibrils and for resensitization [5]. RLC phosophorylation 
was performed, either on the isolated light chain or on the hybrid 
myosin, by addition of myosin light chain kinase (MLCK) (courtesy 
of Dr. Deqin Li) in the following buffer: 150 mM KCl, 5 mM MgCl,, 
1OpM Tris pH 7.5, 1 mM DTT, 0.2 mM CaCl,, 2.5 mM [r-‘*P]ATP, 
10 pg/ml calmodulin, 10 mg/ml MLCK. Actin-activated Mg-ATPase 
rates were measured for thirty minutes, in the presence (0.2 mM) and 
absence of calcium, under standard conditions at low ionic strength (40 
mM NaCl, 2 mM MgCl,, 10 mM phosphate, 1.0 mM ATP, 0.1 mM 
EGTA, 3 mM NaN,, pH 7.0) using 32P release [21]. At the end of each 
assay aliquots were removed, centrifuged, washed and analyzed by 
SDS/acrylamide gel electrophoresis so as to ensure that no light chain 
dissociation had occurred during ATP hydrolysis. Densitometry of 
Fast green stained SDSlacrylamide gels was performed on all brain 
RLC hybrids by standard procedures [5]. 
The three sequences described here can be accessed from the EMBL 
data library as 231721 (FY53), 232518 (yu63) and 232519 (TY21). 
3. Results 
Analysis of ten positive clones revealed direct sequenc- 
ing evidence for the presence of three distinct RLC se- 
quences in rat brain (Fig. 1). As anticipated, we found 
clones representing the sequences obtained by Feinstein 
and colleagues [17](our sequence FY53) and by Taub- 
man and colleagues [22] (our sequence TY21). We were 
able to verify that the deduced amino acid sequence pre- 
sented formerly [17] had lacked only a single N-terminal 
methionine and we were able to extend the cDNA se- 
quence some 44 residues into the 5 non-coding region. 
Regarding the sequence by Taubman and colleagues 
[22], TY21 contains three nucleotide insertions and two 
substitutions with respect to the revised version of the 
sequence from these authors (Genbank Accession no. 
X05566) and these are described in the legend to Fig. 1. 
In addition, we have obtained evidence for the existence 
of a third RLC isoform in brain (our sequence YU63, 
Fig. 1). This partial sequence nabled us to define differ- 
ences from the two previously published sequences which 
are to be found, at both the nucleotide and amino acid 
levels, in the region of amino acids 63-68 (numbering as 
in ref. 22). 
The complete cDNA sequence for RLC FY53 was 
ligated into the pAED expression vector (see section 2), 
overexpressed in E. colt’ BL2 1 and the purified light chain 
was hybridized to desensitized scallop myofibrils (Fig. 2). 
The brain RLCs could be phosphorylated either before 
(Fig. 2B,C; lanes 1 and 2) or after (Fig 2B,C; lanes 3 and 
4) rebinding to form scallop hybrid myosin. The various 
products seen in Fig. 2 were assessed for calcium-de- 
pendent actin-activated MgATPase activity and results 
are presented in Table 1. The brain RLC isoform ex- 
pressed from FY53 was not capable of restoring calcium 
sensitivity to desensitized scallop myofibrils, irrespective 
of the presence or absence of light chain phosphorylation 
and irrespective of whether phosphorylation took place 
on the isolated light chain or subsequent to myosin hy- 
brid formation. 
4. Discussion 
Owing to the fact that a number of myosin II isoforms 
are found in brain [13-l 61, biochemical analysis on prep- 
arations of myosin II from brain necessarily measures 
properties representative of the whole population. Such 
characterization has demonstrated that the actin-acti- 
vated MgATPase rate of brain myosin II is low, 
being < 30 nmol .min-’ . mg-’ even when maximally acti- 
vated, and may be regulated through RLC phosphoryla- 
tion [23-251. Here, we have attempted to define the form 
of regulation of an individual isoform of brain myosin 
Table 1 
Actin-activated MgATPase activities of scallop hybrid myofibrils 
Actin-activated MgATPase Sensitivity Reg/Ess 
@mol phosphate)/(min)(mg) ratio 
Calcium 
(-) (+I (3 
Light chain phosphorylation prior to readdition 
Desensitized 0.26 0.30 0.87 
scallop myofibrils 
Scallop RLC 0.07 0.36 0.19 
Non-phosphorylated rat 0.25 0.27 0.93 
brain RLC 
Phosphorylated rat brain 0.31 0.34 0.91 
RLC 
ND 
ND 
0.86 
0.97 
Light chain phosphorylation subsequent to hybrid formation 
Desensitized 0.16 0.14 1.14 ND 
scallop myofibrils 
Scallop RLC 0.03 0.26 0.12 ND 
Non-phosphorylated rat 0.12 0.17 0.71 0.86 
brain RLC 
Phosphorylated rat brain 0.14 0.15 0.93 0.96 
RLC 
The release of “P [21] was measured under standard conditions in the 
presence (+) (0.1 mM EGTA, 0.2 mM CaCl,) or absence (-) (1.0 mM 
EGTA) of calcium. The ratio of the rates obtained in the absence of 
calcium to those obtained in its presence determines the sensitivity ratio 
(+). The Reg/Ess ratio indicates the level of light chain reuptake by the 
hybrid (maximum level, 1 .O) and is measured by gel densitometry. ND: 
Not determined. Because of variation in activity between different prep- 
arations of scallop myofibrils, the results are tabulated in two groups 
with appropriate controls shown for comparison in both cases. In the 
upper group, phosphorylation of the RLC occurred on the isolated light 
chain prior to hybridization. In the lower group, phosphorylation of 
the RLC took place subsequent to hybridization. 
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N53 GTCCTCTTGTGCGTGCAGCTTCAGGT-TTTWC-cc -44 
TY21 GCGGCGGCMAGCTTCGCAGAGAC GCZTCACTCTTGL~TCTCGCGGCTGAGCAGGGA TTTAAccGccAcc -69 
N53 
TY21 
ATG TCG AGC AAA AAA GCA AAG w A&G ACC ACC AM AAG CGC C-3’ CAG CGC GCA ACG TCC MC GTG TTC GCC ATG 
HSSKKAKTKTTKKRPQRATSNVFAM 
ATG TCG AGC AAA AGA GCG AAG ACC AwAG ACC ACC AAG AAG CGC CCT CAG CGC GCA ACG TCC AAC GTG TTC GCC ATG 
MSSKRAKTKTTKKRPQRATSNVFAM 
75 
75 
N53 
TY21 
TTT GAC CAG TCC CAG ATC CAG GAG TTC AAA GAG GCC TTC AAC ATG ATC G&C CAG AAC CGG GAC GGC TTC ATT GAC 
FDQSQIQEFKEAFNMIDQNRDGFID 
TTT GAC CAG TCC CAG ATC CAG GAG TTC AAA GAG GCC TTC AAC ATG ATC GAC CAG MC CGG GAC GGC TTC ATC GAC 
FDQSQIQEFKEAFNHIDQNRDGFID 
150 
150 
N53 
TY21 
Y"63 
AAG GAG GAC CTG CAC GAC ATG CTC GCG TCT CTG GGG AAG AAC CCC ACC GAC GCC TAC CTG GAC GCC ATG ATG AAC 
KEDLHDHLASLGKNPTDAYLDAMH 
AAG GAG GAC CTG CAC GATATG CTG GCI'TCAATG GGAAAAAAT CCAACT GAT GAATAC CTG GAC GCCATGATGZT 
KEDLHDMLASNGKNPTDEYLDAnHN 
AG GAC CAG ACC GGC GAC TGC CTG GAC GCC ATG ATG AAC 
DQTGDCLDAHMN 
225 
225 
38 
FY53 
TY21 
YU63 
GAG GCC CCG GGC CCC ATC AAT TTC ACC ATG TTC CTC ACC ATG TTT GGA GAG JAG CTG ARC GGC ACC GAC CCA GAG 
E A P G P I N F T M F L T N F G E K L N G T D P E 
GAG GCC CCG GGC CCC ATC AAT TTC ACC ATG TTC CTC ACC ATG TTT GGA GPA AAG CTG AAC GGC ACC GAC CCT GAG 
EAPGPINFTMFLTMFGEKLN T D P 
GAG GCC CCG GGC CCC ATC AAT TTC ACC ATG TTC CTC ACC ATG TTT GGA GAG AAG CTG AAC G,"C ACC GAC CCA GkG 
EAPGPINFTHFLTMFGEKLNGTDPE 
300 
300 
113 
N53 
TX21 
YU63 
GAC GTC ATC AGA AX GCC TTC GCT TGC TTC GAT GAG GAA GCC ACA GGC ACC ATC CAG GAG GAT TAC 
DVIRNAFACFDEEATGTIQEDY 
GAC GTC ATC AGA AAT GCC TTC GCT TGC TTC GAT GAG GAA GCA ATC GGC ACC ATC CAG GAG GAT TAC 
GiC G:C A& Ah A& G& T:C G-k T& T:C GiT GiG G&i G& Ai&, G", A& A:, $.G GkG GiT T;C 
DVIRNAFACFDEEATGTIQEDY 
CTG A6G GAG 
CkG ZG GkG 
L R E 
CPGAGG GAG 
L R E 
375 
375 
188 
FY53 
TY21 
YU63 
CTG CTG ACC ACC ATG GGT GAC CGC TTC ACA GAT GAG GAA GTG GAT GAG CTG TAC AGG GAG GCC CCC 
LLTTMGDRFTDEEVDELYREAP 
CTG CTC ACC ACC ATG GGC GAC CGC TTC ACA GAT GAG GAA GTG GAT GAG CTG TAC AGG GAG GCC CCC 
LLTTKGDRFTDEEVDELYREAP 
CTG CTG ACC ACC ATG GGT GAC CGC TTC ACA GAT GAG GAA GTG GAT GAG CTG TAC AGG GAG GCC CCC 
LLTTNGDRFTDEEVDELYREAP 
ATC GAC AAA 
I D K 
ATC GAC AAA 
A;, Gk Ah 
I D K 
450 
150 
263 
FY53 
TY21 
AAG GGC AAT TTC ARC TAC ATC GAG TTC ACG CGC ATC CTC AAG CAC GGA GCG AAA GAC AA?. GAT GAC TGA 
K G N P N Y T E F T R T r. K I( G A K " K n n l 
A& GEG AiT Tk A& Tic A& GiG T'iC A&? CGC AiC '& AiG CiC GiA G&S A& GiC A.& GiT GiC TGA 
KGNFNYIEFTRILKHGAKDKDD' 
FAG GGC AAT TTC AAC TAC ATC GAG TTC ACG CGC ATC CTC AAG ‘XC GGA GCG AAA GAC AAA GAT GAC TGA 
KGNFNYIEFTRILKHGAKDKDD' 
519 
519 
YU63 332 
FY53 
TY21 
YU63 
FYs3 
TY21 
YU63 
N53 
TYZ1 
YU63 
k-Y53 
TY21 
YU63 
FY53 
YU63 
YU63 
+100 
*loo 
+100 
,200 
,200 
t7.00 
t300 
,300 
,300 
t‘loo 
1345 
,400 
447s 
150" 
+501 
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R-LC DNA SEOUENCE AND AMINO ACID SEOUENCE COMPARISONS: 
Fig. 1. Comparisons of cDNA and ammo acid sequences of three myosin regulatory light chain isoforms found in rat brain. Sequences of the three 
different RLC cDNA sequences cloned here (FY53, TY21 and YU63) and their deduced amino acid sequences are displayed. Numbering: 
5’-untranslated sequences are prefixed by a minus (-) sign; 3’ untranslated sequences are prefixed by a plus (+) sign. The single letter code for amino 
acids is displayed immediately below each codon. YU63 is unique. FY53 is identical to the RLC sequence described by Feinstein et al. [17] except 
that we have been able to extend their sequence further into the S-untranslated region and have completed the coding sequence (underlined). TY21 
is similar to the RLC sequence described by Taubman et al. [22] except hat a number of differences are seen when comparing TY21 with the revised 
version of the sequence submitted by these authors (Genbank Accession no. X05566). These differences are found in the 3’untranslated region of 
the sequence and include insertions of G at +42, C at + 69 and A at + 76 and substitutions T for C at positions + 103 and + 150 (all underlined). 
II from within that population by using scallop hybrid in bacteria and introduction of the expressed product 
myosin as a test system [7,8,11]. In principle, our ap- into a hybrid myosin, can be applied to any myosin 
preach of initial cDNA library screening, use of the isoform present in any complex tissue. 
polymerase chain reaction [26] to generate a full length The lack of calcium-sensitive actin-activated 
RLC cDNA coding sequence followed by incorporation MgATPase activity exhibited by the brain RLC (FY53) 
into a prokaryotic expression vector, its overexpression hybrid myosins (Fig. 2 and Table 1) was unexpected. 
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Fig. 2. Hybridization of expressed brain regulatory light chain with desensitized scallop myofibrils. (A,B) SDS/15% acrylamide gels stained with Fast 
green. (C) Autoradiograph of gel seen in B. Intact scallop myofibrils (A2) were desensitized (A3) then incubated with scallop RLC (control) (A4) 
or with rat brain RLC (FY53) (B,C, lanes 2-4) purified after overexpression i bacteria (B,C, lanes 1). Scallop hybrid myofibrils possess brain RLCs 
which are either non-phosphorylated (B,C, lanes 3), or were phosphorylated with MLCK either before (B,C, lanes 2) or after (B,C, lanes 4) 
hybridization. Loadings: 10 @g per lane. Lane Al: molecular weight standards. BRLC, brain regulatory light chain; SRLC, scallop regulatory light 
chain. Note that in these SDS/l5% acrylamide gels, the scallop essential light chains run at the same location as the scallop regulatory light chain 
[4,51. 
RLCs from both smooth and non-muscle myosins, capa- 
ble of exerting control by derepression through RLC 
phosphorylation, have been shown to be capable of re- 
storing calcium sensitivity to desensitized scallop myosin 
[7,12]. Previously, only RLCs from myosins found 
within thin-filament regulated muscles have produced 
calcium insensitive hybrids under these conditions [7-91. 
The hybrid myosin rates seen here (Table 1) were ele- 
vated both in the presence and absence of calcium, simi- 
lar to desensitized rates, as observed previously for pure 
vertebrate hybrids [7]; calcium insensitive inhibited rates, 
also reported for this type of hybrid [8,9], were not ob- 
served. RLC phosphorylation had no effect on these 
results, whether performed before, or after, hybrid for- 
mation (Table 1). It is unlikely that the absence of a 
blocked N terminus in the expressed FY53 RLC is re- 
sponsible for disrupting regulation for full restoration of 
function has been achieved previously with scallop RLCs 
expressed in bacteria [lo]. Indeed, disruption of either 
the divalent cation binding site [9,10], or the carboxyl 
terminus [lo], is required in order to eliminate regulation 
while maintaining integrity of light chain binding. The 
possible significance of heavy chain phosphorylation as 
a regulatory mechanism in brain myosin [24,25,27,28], 
remains to be established but should not effect interpre- 
tation of the hybrid myosin results. 
One interpretation would be that these results indicate 
the possible presence, in brain cells, of a myosin II 
isoform regulated by control proteins associated with the 
thin filament. While the presence of a thin filament con- 
trolled myosin in brain cells may appear unlikely, we 
note that other components associated with thin filament 
linked regulation, such as tropomyosin [31], troponin 
[32] and caldesmon [33], have also been found in brain. 
Alternatively, it should also be borne in mind that the 
precise alignment of residues at the interface of the regu- 
latory and essential light chains on the surface of myosin, 
required for the mechanism of allosteric control in a 
regulatory myosin, may not always be matched appro- 
priately in hybrid molecules. The recently published 
structure of the regulatory domain from scallop myosin 
[29] indicates a key role for Gly”’ in the RLC of that 
structure. Gly”’ provides the two critical contact points 
between region III of the RLC and region I of the ELC 
within the regulatory myosin structure [29] and stabilizes 
the calcium-binding loop of the ELC. This glycine, to- 
gether with flanking residues (MetGlyAsp) are con- 
served in the brain RLC sequences (Fig. 1; amino acid 
residues 130- 132), raising the question as to why they are 
not capable of restoring functionality in these hybrid 
molecules (Table 1). It may be that the structure of the 
light chain interface is perturbed in these hybrids, 
thereby altering either the calcium binding domain itself 
or the allosteric relay mechanism. In this regard it may 
be noted that earlier hybrid studies detected a perturba- 
tion of function at the calcium specific site when pure 
hybrid myosins, formed using RLCs from regulatory 
myosins that operate through a phosphorylatory mecha- 
nism, exhibited calcium dependent regulation but with 
calcium binding curves shifted to higher free calcium 
levels as compared with intact scallop myosin [7]. 
In addition to extending the known cDNA sequence 
of one RLC isoform [17] further 5, and defining a strain- 
variant of another RLC isoform [22], we also present 
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evidence here for the existence of a third RLC isoform 
in brain not described previously (Fig. 1). The major 
region of difference defined here, ammo acids 63-68, 
appear to reside within a flexible loop [29,30] on the 
carboxyl side of the metal binding site, immediately adja- 
cent to the F-helix of the E-F hand. This site may be of 
potential significance in the modulation of binding affin- 
ity between the RLC and the myosin heavy chain, a role 
which may help maintain the integrity of the metal bind- 
ing site, crucial for inhibition and regulation [9,10]. 
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